Link
The NCI announced a collaboration with the Multiple Myeloma Research Foundation (MMRF) to integrate MMRF's wealth of genomic and clinical data on the disease into the GDC. The MMRF is the first non-profit to donate information to the GDC and serves as a research and advocacy organization conducting clinical studies that incorporate whole-genome, whole-exome, and RNA sequencing into their study analyses. Multiple myeloma is the second most common blood cancer, but large amounts of genomic data on this disease and other cancers have not been readily accessible to the research community. The contribution includes data from ongoing MMRF studies as well as their newest genomic study, “Relating Clinical Outcomes in MM to Personal Assessment of Genetic Profile” (CoMMpass, NCT01454297). The trial has enrolled more than 1,150 patients to date and is currently the largest genomic and clinical study of this disease. The contribution of MMRF data will enable the discovery of potentially actionable and life-changing insights into multiple myeloma and its response to therapy that could be used by cancer researchers, doctors and patients. For more information, please contact GDC Support.